Synopsis
Synopsis
0
CEP/COS
0
VMF
0
FDF
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
Annual Reports
NA
1. Bladuril
2. Flavoxate
3. Hydrochloride, Flavoxate
4. Spasuret
5. Urispas
6. Uronid
1. 3717-88-2
2. Flavoxate Hcl
3. Urispas
4. Dw-61
5. Flavoxate (hydrochloride)
6. Bladderon
7. Peflate
8. Spasmal
9. Nsc-114649
10. Dw 61 (flavoxate)
11. 2-(piperidin-1-yl)ethyl 3-methyl-4-oxo-2-phenyl-4h-chromene-8-carboxylate Hydrochloride
12. Rec 7/0040
13. Rec-7-0040;dw61
14. Flavoxate Hydrochloride
15. Chebi:5089
16. 2-piperidinoethyl 3-methyl-4-oxo-2-phenyl-4h-1-benzopyran-8-carboxylate Hydrochloride
17. 9c05j6089w
18. Piperidinoethyl-3-methylflavone-8-carboxylate Hydrochloride
19. Spasuret Hydrochloride
20. Dsstox_cid_27764
21. Dsstox_rid_82541
22. Dsstox_gsid_47784
23. 4h-1-benzopyran-8-carboxylic Acid, 3-methyl-4-oxo-2-phenyl-, 2-(1-piperidinyl)ethyl Ester, Hydrochloride
24. Genurin
25. Spasuret
26. Urispadol
27. Verrispasmin Amp.
28. 2-piperidin-1-ylethyl 3-methyl-4-oxo-2-phenylchromene-8-carboxylate;hydrochloride
29. Ak 123
30. Nsc114649
31. Rec-7-0040
32. Ncgc00016636-01
33. Cas-3717-88-2
34. Ccris 1950
35. Sr-01000872667
36. Unii-9c05j6089w
37. Prestwick_884
38. Einecs 223-066-4
39. Mfcd00072099
40. Nsc 114649
41. Rec 7-0040
42. Flavoxate Hydrochloride [usan:usp:jan]
43. Rec-7-0040 Hcl
44. Mls002154247
45. Schembl124540
46. Dw61
47. Chembl1200875
48. Dtxsid1047784
49. Hy-b0549a
50. 1-piperidinoethanol, Hydrochloride
51. Hms1568b06
52. Bcp13298
53. Flavoxate Hydrochloride [mi]
54. Tox21_110537
55. Flavoxate Hydrochloride (jp17/usp)
56. Flavoxate Hydrochloride [jan]
57. S4027
58. Flavoxate Hydrochloride [usan]
59. Akos025310107
60. Tox21_110537_1
61. Ac-1093
62. Ccg-220242
63. Flavoxate Hydrochloride [mart.]
64. 1-piperidineethanol, 3-methyl-4-oxo-2-phenyl-4h-1-benzopyran-8-carboxylate, Hydrochloride
65. 2-piperidin-1-ylethyl 3-methyl-4-oxo-2-phenylchromene-8-carboxylate Hydrochloride
66. Flavoxate Hydrochloride [usp-rs]
67. Flavoxate Hydrochloride [who-dd]
68. Dw-61;rec-7-0040;dw61
69. Ncgc00016636-05
70. 4h-1-benzopyran-8-carboxylic Acid, 3-methyl-4-oxo-2-phenyl-, 2-piperidinoethyl Ester, Hydrochloride
71. As-12321
72. Smr000499576
73. F0717
74. Flavoxate Hydrochloride [ep Impurity]
75. Flavoxate Hydrochloride [orange Book]
76. Ft-0658191
77. Ft-0668549
78. Sw197005-3
79. Flavoxate Hydrochloride [ep Monograph]
80. D00718
81. D90684
82. Flavoxate Hydrochloride [usp Monograph]
83. Flavoxate Hydrochloride, >=98% (hplc), Solid
84. J-521367
85. Sr-01000872667-1
86. Q27106648
87. Wln: T66 Bo Evj Cr& D1 Jvo2- At6ntj &gh
88. 4h-1-benzopyran-8-carboxylic Acid, 2-piperidinoethyl Ester, Hydrochloride
89. Flavoxate Hydrochloride, European Pharmacopoeia (ep) Reference Standard
90. Flavoxate Hydrochloride, United States Pharmacopeia (usp) Reference Standard
91. 1-(2-{[(3-methyl-4-oxo-2-phenyl-4h-chromen-8-yl)carbonyl]oxy}ethyl)piperidinium Chloride
92. 2-(piperidin-1-yl)ethyl3-methyl-4-oxo-2-phenyl-4h-chromene-8-carboxylatehydrochloride
93. 2-piperidinoethyl-3-methyl-4-oxo-2-phenyl-4h-1-benzopyran-8-carboxylate Hydrochloride
94. 4h-1-benzopyran-8-carboxylic Acid, 2-(1-piperidinyl)ethyl Ester, Hydrochloride
Molecular Weight | 427.9 g/mol |
---|---|
Molecular Formula | C24H26ClNO4 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 6 |
Exact Mass | 427.1550360 g/mol |
Monoisotopic Mass | 427.1550360 g/mol |
Topological Polar Surface Area | 55.8 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 631 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Flavoxate hydrochloride |
Drug Label | Flavoxate hydrochloride tablets contain flavoxate hydrochloride, a synthetic urinary tract spasmolytic.Chemically, flavoxate hydrochloride is 2-piperidinoethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate hydrochloride. The empirical formula... |
Active Ingredient | Flavoxate hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 100mg |
Market Status | Prescription |
Company | Impax Pharms; Epic Pharma; Paddock |
2 of 2 | |
---|---|
Drug Name | Flavoxate hydrochloride |
Drug Label | Flavoxate hydrochloride tablets contain flavoxate hydrochloride, a synthetic urinary tract spasmolytic.Chemically, flavoxate hydrochloride is 2-piperidinoethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate hydrochloride. The empirical formula... |
Active Ingredient | Flavoxate hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 100mg |
Market Status | Prescription |
Company | Impax Pharms; Epic Pharma; Paddock |
Parasympatholytics
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)
Urological Agents
Drugs used in the treatment of urological conditions and diseases such as URINARY INCONTINENCE and URINARY TRACT INFECTIONS. (See all compounds classified as Urological Agents.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?